An IFN-γ-related signature predicts prognosis and immunotherapy response in bladder cancer: Results from real-world cohorts

Bladder cancer (BLCA) is featured with high incidence and mortality. Whether the IFN-γ signaling could be used as an immunotherapy determinant for BLCA has not been fully confirmed. In this study, the transcriptome data and clinical information of BLCA samples were collected from The Cancer Genome A...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Hao, Deng, Dingshan, Qi, Tiezheng, Liu, Zhi, Wu, Longxiang, Yuan, Junbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846040/
https://www.ncbi.nlm.nih.gov/pubmed/36685901
http://dx.doi.org/10.3389/fgene.2022.1100317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846040/
https://www.ncbi.nlm.nih.gov/pubmed/36685901
http://dx.doi.org/10.3389/fgene.2022.1100317

Ejemplares similares